ArticleBlood advances2026
Increased gene therapy efficacy through the use of extended half-life clotting factors.
Dries De Wolf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBlood advances2026
Dries De Wolf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.